Patents by Inventor Annick Mercenier

Annick Mercenier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210060097
    Abstract: Use of a sugar selected from lactose, fructose and raffinose, for increasing serpin expression in Bifidobacterium longum strain CNCM I-2618.
    Type: Application
    Filed: December 27, 2018
    Publication date: March 4, 2021
    Inventors: Stephane Duboux, Gabriela Bergonzelli Degonda, Annick Mercenier, Muzi Tangyu
  • Publication number: 20200330589
    Abstract: A composition including protein hydrolysates derived from milk is obtained by the treatment of enzymes derived from microorganisms. A trypsin-like enzyme and a chymotrypsin-like enzyme are used. The composition is in particular intended for inducing tolerance in infants with the effect of modulating the potential occurrence of allergies later in life. The composition can also be used in sick adult patients. Preferably the composition is an infant formula, infant follow-up formula, growing-up milk or baby food or an enteral complete nutritional composition.
    Type: Application
    Filed: July 6, 2020
    Publication date: October 22, 2020
    Inventors: Michael Affolter, Isabelle Bureau-Franz, Francoise Maynard, Annick Mercenier, Alexandre Panchaud
  • Patent number: 10576110
    Abstract: The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicating L. johnsonii La1 NCC533 (deposit number CNCM I-1225) for use in the treatment or prevention of disorders related to the immune system including infections.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: March 3, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Valerie Petit, Clara Garcia-Rodenas, Monique Julita, Guenolee Prioult, Annick Mercenier, Sophie Nutten
  • Publication number: 20200009202
    Abstract: The subject or the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
    Type: Application
    Filed: March 11, 2019
    Publication date: January 9, 2020
    Inventors: Veronique Dennin, Gregory John Leyer, Annick Mercenier, Sophie Nutten, Bruno Pot
  • Patent number: 10456429
    Abstract: The present invention relates to the topical use of Bifidobacterium longum subsp. longum CNCM I-2618, as a pro-pigmenting agent, in particular in the prevention and/or treatment of alterations of skin and/or hair color homogeneity and for creating a uniform complexion.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: October 29, 2019
    Assignees: L'OREAL, NESTEC S.A.
    Inventors: Lionel Breton, Audrey Gueniche, Michela Zuccolo, Annick Mercenier, Guénolé Prioult
  • Patent number: 9907781
    Abstract: The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: March 6, 2018
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Anurag Singh, Sebastien Holvoet, Fabiola Dionisi, Lucas Actis Goretta
  • Publication number: 20180028581
    Abstract: The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
    Type: Application
    Filed: March 13, 2017
    Publication date: February 1, 2018
    Inventors: VERONIQUE DENNIN, GREGORY John LEYER, ANNICK MERCENIER, SOPHIE NUTTEN, BRUNO POT
  • Patent number: 9839656
    Abstract: A composition comprising specific Lactobacillus helveticus strains is provided for reducing the symptoms of allergies originating from food, respiratory or contact allergens. Preferably the composition reduces symptoms of allergies (secondary prevention) while also able to reduce sensitization (primary prevention).
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: December 12, 2017
    Assignee: Nestec S.A.
    Inventors: Sebastien Holvoet, Annick Mercenier, Marietta Weiss, Adrian Walter Zuercher
  • Publication number: 20170000880
    Abstract: A composition including protein hydrolysates derived from milk is obtained by the treatment of enzymes derived from microorganisms. A trypsin-like enzyme and a chymotrypsin-like enzyme are used. The composition is in particular intended for inducing tolerance in infants with the effect of modulating the potential occurrence of allergies later in life. The composition can also be used in sick adult patients. Preferably the composition is an infant formula, infant follow-up formula, growing-up milk or baby food or an enteral complete nutritional composition.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 5, 2017
    Inventors: Michael Affolter, Isabelle Bureau-Franz, Francoise Maynard, Annick Mercenier, Alexandre Panchaud
  • Patent number: 9498502
    Abstract: Bifidobacterium breve CNCM I-3865 (NCC2950), a composition comprising Bifidobacterium breve CNCM I-3865 (NCC2950), and the use of Bifidobacterium breve CNCM I-3865 (NCC2950) in the prevention or treatment of allergic diarrhoea are provided. The Bifidobacterium breve CNCM I-3865 (NCC2950) can be in a non-replicating form and can be administered to at least partially treat allergic diarrhoea or at least partially reduce the risk of developing allergic diarrhoea.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: November 22, 2016
    Assignee: Nestec S.A.
    Inventors: Sophie Nutten, Annick Mercenier, Swantje Duncker
  • Patent number: 9486004
    Abstract: A composition including protein hydrolysates derived from milk is obtained by the treatment of enzymes derived from microorganisms. A trypsin-like enzyme and a chemotrypsin-like enzyme are used. The composition is in particular intended for inducing tolerance in infants with the effect of modulating the potential occurrence of allergies later in life. The composition can also be used in sick adult patients. Preferably the composition is an infant formula, infant follow-up formula, growing-up milk or baby food or an enteral complete nutritional composition.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: November 8, 2016
    Assignee: Nestec S.A.
    Inventors: Michael Affolter, Isabelle Bureau-Franz, Francoise Maynard, Annick Mercenier, Alexandre Panchaud
  • Publication number: 20160303226
    Abstract: Heat treated Bifidobacterium lactis NCC 2818 reduces the symptoms of allergies in different groups of patients, such as allergies originating from food allergens in young children, or infants, and food, respiratory and cutaneous allergens in children, adults and household pets. The heat treated Bifidobacterium lactis NCC 2818 may be administered alone or in a composition. A reduction of allergy symptoms has been measured, in vivo, in a mouse allergy model.
    Type: Application
    Filed: November 4, 2014
    Publication date: October 20, 2016
    Inventors: Annick Mercenier, Guenolee Prioult
  • Patent number: 9456630
    Abstract: The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAAA-999.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: October 4, 2016
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Stephanie Blum-Sperisen, Florence Rochat
  • Patent number: 9439449
    Abstract: A complete nutritional composition comprising Bifidobacterium strains or probiotic is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition reduces symptoms of allergies (secondary prevention) and also reduces sensitization (primary prevention). The composition comprises a probiotic of the genus Bifidobacterium.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: September 13, 2016
    Assignee: Nestec S.A.
    Inventors: Sebastien Holvoet, Annick Mercenier, Adrian Zuercher
  • Publication number: 20160250265
    Abstract: The present invention relates to non-replicating probiotic micro-organisms and their health benefits. For example, the present invention relates to compositions comprising non-replicating probiotic micro-organisms for use in the treatment of prevention of upper respiratory tract infections and/or their symptoms. Embodiments of the present invention can help parents to protect their children from such upper respiratory tract infections.
    Type: Application
    Filed: May 11, 2016
    Publication date: September 1, 2016
    Inventors: Valerie Petit, Clara Lucia Garcia-Rodenas, Monique Julita, Annick Mercenier, Guenolee Prioult, Sophie Nutten
  • Patent number: 9375454
    Abstract: The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: June 28, 2016
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Sophie Nutten, Guenolee Prioult
  • Patent number: 9370538
    Abstract: The present invention relates to non-replicating probiotic micro-organisms and their health benefits. For example, the present invention relates to compositions comprising non-replicating probiotic micro-organisms for use in the treatment of prevention of upper respiratory tract infections and/or their symptoms. Embodiments of the present invention provide means to help parents to protect their children from such upper respiratory tract infections.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: June 21, 2016
    Assignee: Nestec S.A.
    Inventors: Valerie Petit, Clara Lucia Garcia-Rodenas, Monique Julita, Annick Mercenier, Guenolee Prioult, Sophie Nutten
  • Publication number: 20160158297
    Abstract: Compositions include probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system.
    Type: Application
    Filed: February 10, 2016
    Publication date: June 9, 2016
    Inventors: Annick Mercenier, Antoine Wermeille, Audrey Demont, Guenolee Prioult
  • Patent number: 9345728
    Abstract: The present invention relates to non-replicating probiotic micro-organisms and their health benefits. In particular, the present invention provides a means to help parents to protect their children from gastro-intestinal infections, in particular diarrhea. One embodiment of the present invention relates to a composition comprising non-replicating probiotic micro-organisms for use in the prevention or treatment of gastrointestinal infections in children.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: May 24, 2016
    Assignee: Nestec S.A.
    Inventors: Valerie Petit, Clara Lucia Garcia-Rodenas, Monique Julita, Annick Mercenier, Guenolee Prioult, Sophie Nutten
  • Patent number: 9320767
    Abstract: The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: April 26, 2016
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Antoine Wermeille, Audrey Demont, Guenolee Prioult